ONCOGENEX PHARMACEUTICALS IN - COM (OGXI) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2014 to Q3 2017

Type / Class
Equity / COM
Symbol
OGXI
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of ONCOGENEX PHARMACEUTICALS IN - COM (OGXI) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2017 Q3 0 $0 -$1,134,240 0
2017 Q2 3,238,087 $1,165,240 -$414,604 $0.36 21
2017 Q1 4,180,481 $1,845,000 +$380,088 $0.44 23
2016 Q4 4,233,813 $2,114,000 -$665,453 $0.50 27
2016 Q3 5,553,540 $2,808,000 +$683,493 $0.51 27
2016 Q2 3,985,501 $3,990,000 -$472,444 $1.00 34
2016 Q1 4,548,826 $3,111,000 -$1,797,962 $0.68 37
2015 Q4 5,852,727 $7,069,000 -$1,596,854 $1.21 47
2015 Q3 6,480,459 $14,434,000 -$3,114,831 $2.23 48
2015 Q2 7,800,012 $18,171,330 -$1,689,187 $2.33 51
2015 Q1 8,589,160 $18,432,000 -$1,804,146 $2.15 50
2014 Q4 9,352,997 $21,367,290 -$2,193,074 $2.29 59
2014 Q3 9,797,221 $26,146,000 -$4,708,901 $2.67 53
2014 Q2 11,361,651 $42,326,000 +$15,874,735 $3.73 66
2014 Q1 6,051,026 $71,076,318 -$4,564,568 $11.76 71